Purpose of review Chronic pain after surgery is a major public health problem and a major concern for perioperative physicians. Thoracic surgery presents a unique challenge, as thoracotomy is among the highest risk surgeries to develop persistent postsurgical pain. The purpose of this review is to discuss the relevance of research in pain epigenetics to patients with persistent pain after thoracic surgery.
INTRODUCTION
Chronic postsurgical pain is a major concern of surgeons and perioperative physicians as it represents the most common complication after thoracotomy [1, 2] . Although nearly all patients have some degree of acute pain after surgery, 30-40% develop persistent chronic pain [3] [4] [5] [6] . It is currently unclear what specific modifications occur in neural circuits responsible for nociception and what changes occur in biochemical pathways that increase the risk of developing persistent pain after surgery. Persistent postoperative pain after thoracic surgery is a key public health issue that needs to be addressed so that the prevention of acute and chronic pain may be better targeted [2] . Acute intercostal nerve injury and surgical tissue trauma may be the cause of chronic pain after thoracic surgery; however, there does not appear to be a strong correlation between presence of nerve injury and the development of chronic postsurgical pain [2, 7] .
There appear to be several important risk factors for developing persistent pain after surgery. One important predictor of persistent postoperative pain is presence of severe postoperative acute pain [8, 9] . Interestingly, based on recent data, the presence of preoperative chronic pain does not necessarily predict severe postoperative pain [10] . Early postoperative neuropathic pain is a risk factor [8] . Preoperative anxiety is an important risk factor for developing persistent postsurgical pain and may be a risk factor that should be optimized prior to surgery [3, 11] . Female sex and increasing age also appear to be risk factors in developing chronic postoperative pain [3] .
One important question that needs to be addressed is whether there is a difference in the incidence of chronic pain after video-assisted thoracoscopic surgery (VATS) or thoracotomy. It appears that the risk of developing chronic neuropathic pain after surgery is not related to mode of thoracic surgery whether VATS or thoracotomy [8, 12] . Therefore, all patients presenting for thoracic surgery are at high risk of developing significant long-term morbidity from pain after surgery.
Recent advances in chronic pain medicine have linked innate immunity to the development and maintenance of chronic pain syndromes [13 & ]. Because of acute local and systemic inflammation that occurs after surgery, it is possible that the inflammatory environment postoperatively contributes to the generation of long-term chronic pain. In support of this hypothesis, patients undergoing lung transplantation surgery requiring perioperative and postoperative immune suppression have a lower incidence of developing chronic pain [14] .
The root cause of the development of chronic pain after surgery, considering the aforementioned risk factors, is likely multifactorial with influences from both genetics (nature) and the environment (nurture). Epigenetics is a means by which the environment can alter the expression of genes [15] . The surgical stimulus that incites chronic pain may change and alter gene expression by epigenetic mechanisms. In this review, we will discuss the interplay between the environment and gene expression and focus on the key epigenetic targets as they relate to the development of chronic pain. There is promise from preclinical animal models in blocking epigenetic modification during acute pain that may prevent the progression to chronic postsurgical pain [16,17 && ,18] .
ENVIRONMENT, GENETICS AND PAIN
The role of genetics in pain phenotypes is undeniable. Genetic polymorphisms in a single gene can have such a profound effect on the sensation of pain that they can render individuals either insensate to pain or exquisitely sensitive to nonpainful stimuli. The gene SCN9A encodes a sodium channel (NaV1.7), and if mutated can cause either a gain of function resulting in erythermalgia or loss of function resulting in the inability to sense pain [19] [20] [21] [22] . The authors of this remarkable finding call the inability to sense pain as a result of a polymorphic SCN9A gene 'channelopathy-associated insensitivity to pain' [20] . One patient cited in this manuscript, was found street performing including walking barefoot over hot coals and placing sharp knives through his skin [20] . This study demonstrates the key role of genetics in nociception. In addition to purely genetic causes of altered nociception, environmental triggers of chronic pain may predispose to central sensitization. The role of environment in disease is often examined using twin studies. The question of whether identical twins both have an equivalent predisposition to the chronic pain remains incompletely answered; however, there are significant environmental factors, such as smoking, that correlate with chronic pain. These environmental factors possibly act though epigenetic mechanisms [23 & ,24] . The remarkable plasticity of gene expression influenced by the environment may account for the variability in susceptibility for chronic pain among individuals sharing the same genetic predisposition. The aim of future studies should be on elucidating the modifiable environmental factors that may reduce the risk of developing chronic pain after surgery.
PAIN EPIGENETICS
Epigenetic mechanisms involve changing the likelihood of gene expression by altering the chemical or physical structure of DNA [15] . Structural and chemical changes in DNA may be influenced by experience (acute pain and perioperative inflammation) potentially predisposing patients to chronic pain after nerve injury because of surgical insult [18,25,26 && ]. Epigenetic modifications are an attractive target for therapeutics to block the development of chronic pain after surgery, as they are remarkably reversible and heavily influenced by environment.
One demonstration of how environmental influences can induce changes in gene expression through epigenetic modification came from the honeybee. It was discovered that feeding genetically identical larvae royal jelly beyond 3 days induces differential methylation in a gene that encodes a DNA methyltransferase (DNMT3) important in global gene expression [27] . The decrease in methylation of this gene, which occurs via exposure to the royal jelly beyond 3 days, results in the generation of a queen phenotype [27, 28] . Remarkably demonstrated in the bee, feeding a nutritionally unique diet can cause epigenetic modification that profoundly influences phenotype. In contrast to the royal jelly, the inflammatory, stressful and traumatic nature of necessary surgical intervention may induce deleterious methylation changes that
KEY POINTS
Chronic pain after thoracic surgery is a major public health concern.
Epigenetic modifications may have a role in the development of chronic pain after surgery.
Preclinical studies suggest that targeting epigenetic mechanisms may prevent the development of chronic pain after nerve injury.
Thoracic anesthesia result in a predisposition to develop a chronic pain after surgery. Possible epigenetic changes that occur in the perioperative period could be the driving force behind the development of persistent postoperative pain [18, 29] .
Epigenetic DNA changes occur via two major mechanisms: histone modification and DNA methylation [15] . The data relating to chronic pain via these two major mechanisms will be reviewed here.
HISTONE MODIFICATIONS AND THEIR ROLE IN THE EPIGENETICS OF PAIN
Scaffold proteins encircled by loops of DNA in the nucleosome are called histones. Histone proteins have protruding N-terminal tails that contain positively charged lysine residues that are sites for acetylation [30] . Histone acetylases (HAT) and deacetylases (HDAC) transfer or remove an acetyl group (from acetyl CoA) to and from positively charged lysine residues on histone tails that neutralize the charge. The positive charge on histone lysine residues attracts negatively charged DNA. Neutralizing the charge with an acetyl group weakens the binding of DNA to its histone scaffold [30] . Dissociation of DNA from histones via HATs relatively increases gene expression whereas HDAC exposes the positively charged lysine residues enhancing DNA attraction to histones and decreasing the likelihood of transcription. In addition to acetylation, histones may also be modified by methylation, phosphorylation, deamination and other mechanisms [30] .
It has been shown that expression of HDAC is downregulated following spared nerve injury in animal models of neuropathic pain [31 & ]. This indicates (theoretically) that global gene expression is facilitated by HDAC in neuropathic pain models. In addition to this finding, a molecular mechanism for the suppression of gad2, a gene that encodes glutamic acid decarboxylase 65 important in presynaptic g-aminobutyric acid (GABA) synthesis, involves HDAC [32] . In this study, Zhang et al. [32] demonstrated that using HDAC inhibitors and inducing a state of hyperacetylation caused analgesia in animals with inflammatory pain by increasing GAD65 activity. This exciting study suggests an epigenetic approach to treat and prevent chronic pain may prove successful.
HDAC inhibitors hold promise as an epigenetic treatment for the prevention of chronic pain in animal models. Given as an intrathecal infusion prior to nerve injury in rats, HDAC inhibitors cause reduced hypersensitivity relative to untreated controls [17 && ]. This effect was not present in animals treated with HDAC inhibitors at the same time as nerve injury. This suggests that histone deacetylation during nerve injury is responsible for mechanical hypersensitivity and is reversible with HDAC inhibitor pretreatment. This preclinical study suggests promise in preventing nerve injury related histone modifications with HDAC inhibitors [17 && ]. This is an attractive approach when the risk of nerve injury and persistent postsurgical pain is high as in patients undergoing thoracic surgery.
Another recent study showed that expression of metabotropic glutamate receptor 2 (mGlu2) is regulated by histone acetylation in the dorsal root ganglion and mediates pain phenotype [33] . In order to achieve full transcriptional activity at the mGlu2 gene, deacetylation at the gene encoding nuclear factor-kB transcription factor p65/RelA must occur. It has been recently demonstrated that the treatment with histone deacetylase inhibitors causes analgesia and also increased expression of mGlu2 in the DRG without affecting other metabotropic glutamate receptors [33] . This is a key finding linking histone acetylation to nociceptive phenotype. This exciting preclinical discovery suggests that therapeutic targets for treating and preventing chronic pain may be histone deacetylase inhibitors or mGlu2 agonists.
There is a strong link between chronic pain and inflammatory reaction emerging in the literature [13 & ]. There are many pathways of interaction between the nervous system and innate immunity. One of those pathways has a possible epigenetic linkage [34 & ]. Mice treated with partial sciatic nerve ligation to induce chronic pain had an increase in histone H3 acetylation in the promoter regions of the genes encoding macrophage inflammatory protein 2 (MIP-2) and C-X-C chemokine receptor 2 (CXCR2). This increased the recruitment and infiltration of inflammatory cells [via increased signaling between the mouse homolog of IL-8 (MIP-2) and its receptor CXCR2] [34 & ]. When treated with an inhibitor for HAT (preventing histone hyperacetylation), mice had a reduction in neuroinflammation and pain. This suggests a role for epigenetic modification in pain via modulating neuroinflammation [34 & ]. This also supports the growing link between chronic pain and inflammation.
DNA METHYLATION IN PAIN EPIGENETICS
DNA methylation is an epigenetic process by which cytosine residues are methylated by DNMTs in the CG dinucleotide sequence [35, 36] . The degree of DNA methylation is inversely related to gene expression as the bulky methyl groups interfere with gene transcription [37] . It has emerged that covalent methylation of DNA cytosine residues is an important mechanism that regulates chronic pain states and may be another potential epigenetic target to treat and prevent chronic pain [37] .
In a recent study by Qi et al., it was shown that the cystathionine-b-synthase (CBS) expression is epigenetically regulated via DNA methylation in the rat. CBS synthesizes hydrogen sulfide, which is involved in nociceptive signaling. In this study, mice exposed to complete Freunds adjuvant (CFA) had increased mechanical hypersensitivity and elevated CBS expression was found in the dorsal root ganglion [38 & ]. Using methylation-specific PCR and bisulfite sequencing, it was found that CFA-treated animals had less cytosine methylation in the cbs gene relative to control. This suggests that DNA methylation can influence the development of mechanical hypersensitivity in an inflammatory pain model. This result further suggests that DNA methylation may be a potential target for drug development in the treatment and or prevention of chronic pain [38 & ]. In another study in rats, inhibiting DNA methylation with intrathecal 5-azacytidine attenuates the development of thermal hyperalgesia and mechanical allodynia in animals treated with a chronic constriction injury [39] . This suggests that blocking DNMT with 5-azacytidine reduces pain behavior in rats with induced nerve injury. Based on this preclinical study, DNMT inhibitors appear to be another promising epigenetically active therapy to prevent chronic pain after surgery [39] .
There appears to be a significant supraspinal component to chronic pain and persistent postsurgical pain. Exciting work in mice has demonstrated that chronic pain is associated with global DNA methylation changes in the prefrontal cortex [26 && ]. It is well known that the prefrontal cortex is important in modulating chronic pain as well as facilitating depression and anxiety. It was shown that after spared nerve injury, mice had significantly reduced global methylation in the prefrontal cortex and the amygdala using a luminometric methylation assay. Furthermore, this group showed a strong correlation between severity of the behavior and percentage of global methylation, strengthening the link between nerve injury and induced methylation changes in the cortex. This study reinforces that nerve injury after surgery may induce DNA methylation changes that, if inhibited, may prevent the development and progression to persistent pain after surgery.
CONCLUSION
This review is focused on pain epigenetics as a potential target for preventing persistent postoperative pain. Epigenetics is an emerging field in pain medicine as primary evidence is accumulating in preclinical animal models that epigenetic changes occur in chronic pain phenotypes. The interaction between the environment and genes via epigenetics is one that is important in the perioperative setting. Thoracic surgery patients undergoing VATS or thoracotomy have a high risk of developing persistent postsurgical pain. It is possible that surgical trauma and nerve injury triggers a cascade of epigenetic changes that results in altered gene expression and increased risk for developing chronic pain. Altering epigenetic processes with inhibitors of histone modification or DNA methylation may be an attractive target for preventing changes that occur in the perioperative period.
